What is the longest survival period for glioma patients

What is the longest survival period for glioma patients? Glioma is a very harmful neurological tumor. In severe cases, it can cause limb paralysis, epilepsy, etc., and can even endanger life at any time. Therefore, many patients are very worried about their life expectancy when they are diagnosed with this disease. So, what is the longest survival period for glioma patients?

Glioma patients are divided into different levels and types. The patient's survival period is also affected by many factors, including their physical fitness, postoperative recovery, and the treatment methods adopted by the hospital. Generally, patients with grades 1-2 have a longer survival period, about 5-10 years; patients with grades 3-4 have a shorter survival period, about 1 year. Surgical resection combined with assisted radiotherapy and chemotherapy can effectively prolong the patient's life.

1. Surgical treatment: Surgery is still the most effective treatment method at present. Its purpose is to clarify the diagnosis, improve symptoms, reduce tumor burden, and create conditions for further treatment. With the widespread application and improvement of microsurgery and laser, ultrasonic aspiration, and navigation systems, tumors that were previously considered inoperable can now be surgically removed. In particular, the application of intraoperative magnetic resonance imaging and navigation systems has greatly improved the total resection rate of surgery while reducing the risk of surgery. Intraoperative magnetic resonance imaging can measure the size of the resected area, and the functional neuronavigation system can display the location of the surgical field to prevent unnecessary neurological damage.

2. Radiotherapy: In recent years, the main progress of radiotherapy has focused on the application and selection of radiosensitizers, and the improvement of radiation dose, radiation field, and time interval. Most gliomas are insensitive to radiation, so the application of sensitizers to improve the radiation effect can increase the killing effect of radiation on tumor cells. Radiosensitization refers to substances that can enhance the biological effect of ionizing radiation. It is clinically used to enhance the killing ability of radiation on tumors and has great application value in the radiotherapy of tumors. Currently, commonly used sensitizers include nitroimidazoles and bioreductants. Nitroimidazole drugs, such as Misonidazole, SR-2508, R0-03-8799 and other radiosensitizers, can selectively enhance the sensitivity of hypoxic cells to radiation, which is 30% to 70% higher than the effect of radiotherapy alone.

Finally, I would like to remind everyone that if you suffer from this disease, you must go to the hospital for examination and treatment in time, and do not delay the disease, which will lead to an irreparable situation. Early detection and early treatment can ensure a higher cure rate and prolong the life of patients and friends.